{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:51:56Z","timestamp":1793641916159,"version":"4.5.1"},"reference-count":124,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDM"],"published-print":{"date-parts":[[2019,6,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>In recent times, herbals or phytomedicines have become very popular due to their global acceptance as a complementary and alternative remedy. While modern drugs are commercially available only after laboratory validations, clinical trials, as well as approval from drug regulatory authorities, majority of the marketed herbal products lack such scientific evidence of efficacy and safety. This results in herb or herb-drug interaction induced unfavorable clinical outcomes without crucial documentation on their temporal relations and concomitant use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>An online literature search for peer-reviewed articles was conducted on the PubMed, Europe PMC, Medline and Google Scholar portals, using the phrases: complementary &amp; alternative medicine, traditional Chinese medicine, herb-drug interaction, mechanisms of herb-drug interaction, herb-induced toxicity, herbal hepatotoxicity and causality, traditional medicine, viral hepatitis, etc.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The retrieved data showed that globally, patients are attracted to herbal remedies with the misconception that these are completely safe and therefore, use them simultaneously with prescription drugs. Notably, there exists a potential risk of herb-drug interactions leading to some adverse side effects, including hepatotoxicity. The toxicological effect of a drug or herb is due to the inhibition of drug metabolizing enzymes (e.g., cytochrome P450), including interactions with certain prescription drugs through various mechanisms. Several cases of hepatotoxicity due to use of herbals in viral hepatitis-related liver diseases have been recently reported. However, limited experimental data and clinical evidence on herbal pharmacokinetics hamper the evaluation and reporting of adverse reactions and the underlying mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Herb-drug interaction related morbidity is thus an emerging serious public health issue with broad implications for clinicians, pharmaceutical industries and health authorities. Nonetheless, despite increasing recognition of herb-drug interaction, a standard system for interaction prediction and evaluation is still nonexistent. This review article discusses the herb-drug interactions related hepatotoxicity and underlying mechanisms, including drug metabolizing enzymes and their regulation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1389200220666190325141422","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T05:02:33Z","timestamp":1553662953000},"page":"275-282","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":132,"title":["Herb-Drug Interactions and Hepatotoxicity"],"prefix":"10.2174","volume":"20","author":[{"given":"Mohammad K.","family":"Parvez","sequence":"first","affiliation":[{"name":"Department of Pharmacognosy, King Saud University College of Pharmacy, Riyadh 11451, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Rishi","sequence":"additional","affiliation":[{"name":"National Agri-Food Biotechnology Institute, Mohali, Punjab 140306, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cbpa.2008.03.016","volume":"12","author":"Ganesan A.","year":"2008","unstructured":"Ganesan A. The impact of natural products upon modern drug discovery.","journal-title":"Curr Opin Chem Biol"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nature03194","volume":"432","author":"Clardy J.","year":"2004","unstructured":"Clardy J, Walsh C. Lessons from natural molecules.","journal-title":"Nature"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5582\/ddt.2011.v5.6.261","volume":"5","author":"Song P.P.","year":"2011","unstructured":"Song PP, Gao JJ, Kokudo N, Tang W. Standardization of traditional Chinese medicine and evaluation of evidence from its clinical practice.","journal-title":"Drug Discov Ther"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.clinthera.2005.11.004","volume":"27","author":"Kennedy J.","year":"2005","unstructured":"Kennedy J. Herb and supplement use in the US adult population.","journal-title":"Clin Ther"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/15563650701754763","volume":"45","author":"Bronstein A.C.","year":"2007","unstructured":"Bronstein AC, Spyker DA, Cantilena LR, Green J, Rumack BH, Heard SE. 2006 annual report of the american association of poison control centers\u2019 National Poison Data System (NPDS).","journal-title":"Clin Toxicol (Phila)"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.amjmed.2009.10.017","volume":"123","author":"Glisson J.K.","year":"2010","unstructured":"Glisson JK, Walker LA. How physicians should evaluate dietary supplements.","journal-title":"Am J Med"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2174\/1389200211209050640","volume":"13","author":"Chen X-W.","year":"2012","unstructured":"Chen X-W, Sneed KB, Pan SY, Cao C, Kanwar JR, Chew H, Zhou S-F. Herb-Drug interactions and mechanistic and clinical considerations.","journal-title":"Curr Drug Metab"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/sj.bjc.6601560","volume":"90","author":"Werneke U.","year":"2004","unstructured":"Werneke U, Earl J, Seydel C, Horn O, Crichton P, Fannon D. Potential health risks of complementary alternative medicines in cancer patients.","journal-title":"Br J Cancer"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.12109","volume":"37","author":"Bunchorntavakul C.","year":"2013","unstructured":"Bunchorntavakul C, Reddy KR. Review article: Herbal and dietary supplement hepatotoxicity.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/bmj.319.7224.1541","volume":"319","author":"Aithal G.P.","year":"1999","unstructured":"Aithal GP, Rawlins MD, Day CP. Accuracy of hepatic adverse drug reaction reporting in one English health region.","journal-title":"BMJ"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1365-2036.2007.03504.x","volume":"26","author":"Dalton H.R.","year":"2007","unstructured":"Dalton HR. Fellows, H.J: Stableforth, W.; Joseph, M.; Thurairajah, P.H. The role of hepatitis E virus testing in drug-induced liver injury.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1053\/j.gastro.2011.07.051","volume":"141","author":"Davern T.J.","year":"2011","unstructured":"Davern TJ, Chalasani N, Fontana RJ, Hayashi PH, Protiva P, Kleiner DE, Engle RE, Nguyen H, Emerson SU, Purcell RH, Tillmann HL, Gu J, Serrano J, Hoofnagle JH. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury.","journal-title":"Gastroenterology"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/MEG.0b013e3283603e89","volume":"25","author":"Teschke R.","year":"2013","unstructured":"Teschke R, Schulze J, Schwarzenboeck A, Eickhoff A, Frenzel C. Herbal hepatotoxicity: Suspected cases assessed for alternative causes.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-2002-30098","volume":"22","author":"Liddle C.","year":"2002","unstructured":"Liddle C, Goodwin B. Regulation of hepatic drug metabolism: Role of the nuclear receptors PXR and CAR.","journal-title":"Semin Liver Dis"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1006\/bbrc.1999.1887","volume":"266","author":"Omura T.","year":"1999","unstructured":"Omura T. Forty years of cytochrome P450.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=16","first-page":"243","volume":"40","author":"Gonzalez F.J.","year":"1998","unstructured":"Gonzalez FJ. The molecular biology of cytochrome P450s.","journal-title":"Pharmacol Rev"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1042\/bj2810577","volume":"281","author":"Waxman D.J.","year":"1992","unstructured":"Waxman DJ, Azaroff L. Phenobarbital induction of cytochrome P-450 gene expression.","journal-title":"Biochem J"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/dna.1993.12.1","volume":"12","author":"Nelson D.R.","year":"1993","unstructured":"Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R, Gonzalez FJ, Coon MJ, Gunsalus IC, Gotoh O. The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature.","journal-title":"DNA Cell Biol"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/03602539709037591","volume":"29","author":"Rendic S.","year":"1997","unstructured":"Rendic S, Di Carlo FJ. Human cytochrome P450 enzymes: A status report summarizing their reactions, substrates, inducers, and inhibitors.","journal-title":"Drug Metab Rev"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/geno.1995.1149","volume":"28","author":"Gray I.C.","year":"1995","unstructured":"Gray IC, Nobile C, Muresu R, Ford S, Spurr NKA. 2.4-megabase physical map spanning the CYP2C gene cluster on chromosome 10q24.","journal-title":"Genomics"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0076-6879(96)72017-7","volume":"272","author":"Miners J.O.","year":"1996","unstructured":"Miners JO, Birkett DJ. Use of tolbutamide as a substrate probe for human hepatic cytochrome P450 2C9.","journal-title":"Methods Enzymol"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1021\/tx00025a009","volume":"5","author":"Rettie A.E.","year":"1992","unstructured":"Rettie AE, Korzekwa KR, Kunze KL, Lawrence RF, Eddy AC, Aoyama T, Gelboin HV, Gonzalez FJ, Trager WF. Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: A role for P-4502C9 in the etiology of (S)-warfarin-drug interactions.","journal-title":"Chem Res Toxicol"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/clpt.1989.36","volume":"45","author":"Henthorn T.K.","year":"1989","unstructured":"Henthorn TK, Benitez J, Avram MJ. Assessment of the debrisoquin and dextromethorphan phenotyping tests by gaussian mixture distributions analysis.","journal-title":"Clin Pharmacol Ther"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/0006-2952(94)90524-X","volume":"47","author":"Girre C.","year":"1994","unstructured":"Girre C, Lucas D, Hispard E, Menez C, Dally S, Menez J-F. Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics.","journal-title":"Biochem Pharmacol"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1152\/physrev.1997.77.2.517","volume":"77","author":"Lieber C.S.","year":"1997","unstructured":"Lieber CS. Cytochrome P-4502E1: Its physiological and pathological role.","journal-title":"Physiol Rev"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1172\/JCI116064","volume":"90","author":"Kolars J.C.","year":"1992","unstructured":"Kolars JC, Schmiedlin-Ren P, Schuetz JD, Fang C, Watkins PB. Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes.","journal-title":"J Clin Invest"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/S0021-9258(17)43508-3","volume":"259","author":"Schuetz E.G.","year":"1984","unstructured":"Schuetz EG, Guzelian PS. Induction of cytochrome P-450 by glucocorticoids in rat liver. II. Evidence that glucocorticoids regulate induction of cytochrome P-450 by a nonclassical receptor mechanism.","journal-title":"J Biol Chem"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2174\/138920008784746391","volume":"9","author":"Zhou S.F.","year":"2008","unstructured":"Zhou SF, Lai X. An update on clinical drug interactions with the herbal antidepressant St. John\u2019s wort.","journal-title":"Curr Drug Metab"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00280-008-0842-3","volume":"64","author":"Harmsen S.","year":"2009","unstructured":"Harmsen S, Meijerman I, Beijnen JH, Schellens JH. Nuclear receptor mediated induction of cytochrome P450 3A4 by anticancer drugs: A key role for the pregnane X receptor.","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=30","first-page":"615","volume":"29","author":"Quattrochi L.C.","year":"2001","unstructured":"Quattrochi LC, Guzelian PS. Cyp3A regulation: From pharmacology to nuclear receptors.","journal-title":"Drug Metab Dispos"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3945\/jn.108.103572","volume":"139","author":"Li Y.","year":"2009","unstructured":"Li Y, Ross-Viola JS, Shay NF, Moore DD, Ricketts ML. Human CYP3A4 and murine Cyp3A11 are regulated by equol and genistein the pregnane X receptor in a species-specific manner.","journal-title":"J Nutr"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jsps.2018.05.016","volume":"26","author":"Al-Dosari M.S.","year":"2018","unstructured":"Al-Dosari MS, Parvez MK. Novel plant inducers of PXR-dependent cytochrome P450 3A4 expression in HepG2 cells.","journal-title":"Saudi Pharm J"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0009-2797(00)00198-8","volume":"129","author":"Ritter J.K.","year":"2000","unstructured":"Ritter JK. Roles of glucuronidation and UDP-glucuronosyl-transferases in xenobiotic bioactivation reactions.","journal-title":"Chem Biol Interact"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1081\/DMR-100101944","volume":"31","author":"Radominska-Pandya A.","year":"1999","unstructured":"Radominska-Pandya A, Czernik PJ, Little JM, Battaglia E, Mackenzie PI. Structural and functional studies of UDP-glucuronosyltransferases.","journal-title":"Drug Metab Rev"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.taap.2004.01.008","volume":"199","author":"Gregory P.A.","year":"2004","unstructured":"Gregory PA, Lewinsky RH, Gardner-Stephen DA, Mackenzie PI. Regulation of UDP glucuronosyltransferases in the gastrointestinal tract.","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1124\/mol.65.3.479","volume":"65","author":"Eraly S.A.","year":"2004","unstructured":"Eraly SA, Bush KT, Sampogna RV, Bhatnagar V, Nigam SK. The molecular pharmacology of organic anion transporters: from DNA to FDA?","journal-title":"Mol Pharmacol"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1634\/theoncologist.12-8-927","volume":"12","author":"Marchetti S.","year":"2004","unstructured":"Marchetti S, Mazzanti R, Beijnen JH, Schellens JH. Concise review: Clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein).","journal-title":"Oncologist"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"17923","DOI":"10.1073\/pnas.0506483102","volume":"102","author":"Otsuka M.","year":"2005","unstructured":"Otsuka M, Matsumoto T, Morimoto R, Arioka S, Omote H, Moriyama Y. A human transporter protein that mediates the final excretion step for toxic organic cations.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1124\/dmd.108.021337","volume":"36","author":"Aleksunes L.M.","year":"2008","unstructured":"Aleksunes LM, Cui Y, Klaassen CD. Prominent expression of xenobiotic efflux transporters in mouse extraembryonic fetal membranes compared with placenta.","journal-title":"Drug Metab Dispos"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.15761\/BGG.1000109","volume":"1","author":"Al-Dosari M.S.","year":"2016","unstructured":"Al-Dosari MS, Parvez MK. Genetic polymorphisms of drug eliminating enzymes and transporters.","journal-title":"Biomed Genet Genom"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"5962","DOI":"10.1016\/S0021-9258(19)83872-3","volume":"257","author":"Gonzalez F.J.","year":"1982","unstructured":"Gonzalez FJ, Kasper CB. Cloning of DNA complementary to rat liver NADPH-cytochrome c (P-450) oxidoreductase and cytochrome P-450b mRNAs. Evidence that phenobarbital augments transcription of specific genes.","journal-title":"J Biol Chem"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s002280050412","volume":"54","author":"Klotz U.","year":"1998","unstructured":"Klotz U, Ammon E. Clinical and toxicological consequences of the inductive potential of ethanol.","journal-title":"Eur J Clin Pharmacol"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2165\/00003088-200342150-00003","volume":"42","author":"Wang H.","year":"2003","unstructured":"Wang H, LeCluyse EL. Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes.","journal-title":"Clin Pharmacokinet"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"12208","DOI":"10.1073\/pnas.95.21.12208","volume":"95","author":"Bertilsson G.","year":"1998","unstructured":"Bertilsson G, Heidrich J, Svensson K, Asman M, Jendeberg L, Sydow-B\u00e4ckman M, Ohlsson R, Postlind H, Blomquist P, Berkenstam A. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1172\/JCI3703","volume":"102","author":"Lehmann J.M.","year":"1998","unstructured":"Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions.","journal-title":"J Clin Invest"},{"key":"ref=46","first-page":"427","volume":"60","author":"Goodwin B.","year":"2001","unstructured":"Goodwin B, Moore LB, Stoltz CM, McKee DD, Kliewer SA. Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor.","journal-title":"Mol Pharmacol"},{"key":"ref=47","first-page":"242","volume":"29","author":"Gerbal-Chaloin S.","year":"2001","unstructured":"Gerbal-Chaloin S, Pascussi JM, Pichard-Garcia L, Daujat M, Waechter F, Fabre JM, Carr\u00e8re N, Maurel P. Induction of CYP2C genes in human hepatocytes in primary culture.","journal-title":"Drug Metab Dispos"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0300-483X(00)00300-0","volume":"153","author":"Moore J.T.","year":"2000","unstructured":"Moore JT, Kliewer SA. Use of the nuclear receptor PXR to predict drug interactions.","journal-title":"Toxicology"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"7500","DOI":"10.1073\/pnas.130155097","volume":"97","author":"Moore L.B.","year":"2000","unstructured":"Moore LB, Goodwin B, Jones SA, Wisely GB, Serabjit-Singh CJ, Willson TM, Collins JL, Kliewer SASt. John\u2019s wort induces hepatic drug metabolism through activation of the pregnane X receptor.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"15122","DOI":"10.1074\/jbc.M001215200","volume":"275","author":"Moore L.B.","year":"2000","unstructured":"Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B, Liddle C, Blanchard SG, Willson TM, Collins JL, Kliewer SA. Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands.","journal-title":"J Biol Chem"},{"key":"ref=51","first-page":"568106","volume":"2012","author":"Xu L.W.","year":"2012","unstructured":"Xu LW, Jia M, Salchow R, Kentsch M, Cui XJ, Deng HY, Sun ZJ, Kluwe L. Efficacy and side effects of Chinese herbal medicine for menopausal symptoms: A critical review.","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jep.2015.04.006","volume":"169","author":"Hu D.","year":"2015","unstructured":"Hu D, Wang Y, Chen Z, Ma Z, You Q, Zhang X, Liang Q, Tan H, Xiao C, Tang X, Gao Y. The protective effect of piperine on dextran sulfate sodium induced inflammatory bowel disease and its relation with pregnane X receptor activation.","journal-title":"J Ethnopharmacol"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejphar.2014.04.050","volume":"738","author":"Hu D.","year":"2014","unstructured":"Hu D, Wang Y, Chen Z, Ma Z, You Q, Zhang X, Zhou T, Xiao Y, Liang Q, Tan H, Xiao C, Tang X, Zhang B, Gao Y. Artemisinin protects against dextran sulfate-sodium-induced inflammatory bowel disease, which is associated with activation of the pregnane X receptor.","journal-title":"Eur J Pharmacol"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/jpet.114.218750","volume":"352","author":"Zhang J.","year":"2015","unstructured":"Zhang J, Ding L, Wang B, Ren G, Sun A, Deng C, Wei X, Mani S, Wang Z, Dou W. Notoginsenoside R1 attenuates experimental inflammatory bowel disease pregnane X receptor activation.","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1210\/mend.16.5.0828","volume":"16","author":"Moore L.B.","year":"2002","unstructured":"Moore LB, Maglich JM, McKee DD, Wisely B, Willson TM, Kliewer SA, Lambert MH, Moore JT, Pregnane X. Receptor (PXR), Constitutive Androstane Receptor (CAR), and Benzoate X Receptor (BXR) define three pharmacologically distinct classes of nuclear receptors.","journal-title":"Mol Endocrinol"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3389\/fphar.2018.00993","volume":"9","author":"Carazo A.","year":"2018","unstructured":"Carazo A, Dusek J, Holas O, Skoda J, Hyrsova L, Smutny T, Soukup T, Dosedel M, P\u00e1vek P. Teriflunomide is an indirect human Constitutive Androstane Receptor (CAR) activator interacting with Epidermal Growth Factor (EGF) signaling.","journal-title":"Front Pharmacol"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/toxsci\/kfy026","volume":"163","author":"Knebel C.","year":"2018","unstructured":"Knebel C, Neeb J, Zahn E, Schmidt F, Carazo A, Holas O, Pavek P, P\u00fcschel GP, Zanger UM, S\u00fcssmuth R, Lampen A, Marx-Stoelting P, Braeuning A. Unexpected effects of propiconazole, tebuconazole, and their mixture on the receptors CAR and PXR in human liver cells.","journal-title":"Toxicol Sci"},{"key":"ref=58","first-page":"266","volume":"9","author":"Benedict W.F.","year":"1973","unstructured":"Benedict WF, Considine N, Nebert DW. Genetic differences in aryl hydrocarbon hydroxylase induction and benzo(a)pyrene-produced tumorigenesis in the mouse.","journal-title":"Mol Pharmacol"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.1016\/S0021-9258(17)33205-2","volume":"251","author":"Poland A.","year":"1976","unstructured":"Poland A, Glover E, Kende AS. Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase.","journal-title":"J Biol Chem"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.pa.35.040195.001515","volume":"35","author":"Hankinson O.","year":"1995","unstructured":"Hankinson O. The aryl hydrocarbon receptor complex.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0016-5085(90)90963-2","volume":"99","author":"Diaz D.","year":"1990","unstructured":"Diaz D, Fabre I, Daujat M, Saint Aubert B, Bories P, Michel H, Maurel P. Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450.","journal-title":"Gastroenterology"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2165\/00003088-200038060-00003","volume":"38","author":"Fuhr U.","year":"2000","unstructured":"Fuhr U. Induction of drug metaboliing enzymes: Pharmacokinetic and toxicological consequences in humans.","journal-title":"Clin Pharmacokinet"},{"key":"ref=63","first-page":"29","volume":"7","author":"Nguyen N.T.","year":"2015","unstructured":"Nguyen NT, Nakahama T, Nguyen CH, Tran TT, Le VS, Chu HH, Kishimoto T. Aryl hydrocarbon receptor antagonism and its role in rheumatoid arthritis.","journal-title":"J Exp Pharmacol"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/347645a0","volume":"347","author":"Issemann I.","year":"1990","unstructured":"Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators.","journal-title":"Nature"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1073\/pnas.94.9.4312","volume":"94","author":"Forman B.M.","year":"1997","unstructured":"Forman BM, Chen J, Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1124\/mol.51.5.741","volume":"51","author":"Schmiedlin-Ren P.","year":"1997","unstructured":"Schmiedlin-Ren P, Thummel KE, Fisher JM, Paine MF, Lown KS, Watkins PB. Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3.","journal-title":"Mol Pharmacol"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"25125","DOI":"10.1074\/jbc.M201323200","volume":"277","author":"Drocourt L.","year":"2002","unstructured":"Drocourt L, Ourlin JC, Pascussi JM, Maurel P, Vilarem MJ. Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes.","journal-title":"J Biol Chem"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-4781(95)00060-T","volume":"1263","author":"Chen K.S.","year":"1995","unstructured":"Chen KS, DeLuca HF. Cloning of the human 1 alpha,25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements.","journal-title":"Biochim Biophys Acta"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","volume":"6","author":"Goodwin B.","year":"2000","unstructured":"Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, Roth ME, Maloney PR, Willson TM, Kliewer SA. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis.","journal-title":"Mol Cell"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/383728a0","volume":"383","author":"Janowski B.A.","year":"1996","unstructured":"Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha.","journal-title":"Nature"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0092-8674(95)90530-8","volume":"81","author":"Forman B.M.","year":"1995","unstructured":"Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, Perlmann T, Noonan DJ, Burka LT, McMorris T, Lamph WW, Evans RM, Weinberger C. Identification of a nuclear receptor that is activated by farnesol metabolites.","journal-title":"Cell"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0006-2952(03)00586-0","volume":"66","author":"Cheung C.","year":"2003","unstructured":"Cheung C, Akiyama TE, Kudo G, Gonzalez FJ. Hepatic expression of cytochrome P450s in hepatocyte nuclear factor 1-alpha (HNF1alpha)-deficient mice.","journal-title":"Biochem Pharmacol"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1053\/jhep.2001.22176","volume":"33","author":"Jover R.","year":"2001","unstructured":"Jover R, Bort R, Gomez-Lechon MJ, Castell JV. Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: a study using adenovirus- mediated antisense targeting.","journal-title":"Hepatology"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1124\/mol.60.6.1260","volume":"60","author":"Corchero J.","year":"2001","unstructured":"Corchero J, Granvil CP, Akiyama TE, Hayhurst GP, Pimprale S, Feigenbaum L, Idle JR, Gonzalez FJ. The CYP2D6 humanized mouse: effect of the human CYP2D6 transgene and HNF4 alpha on the disposition of debrisoquine in the mouse.","journal-title":"Mol Pharmacol"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0014-5793(98)00746-7","volume":"431","author":"Jover R.","year":"1998","unstructured":"Jover R, Bort R, G\u00f3mez-Lech\u00f3n MJ, Castell JV. Re-expression of C\/EBP alpha induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells.","journal-title":"FEBS Lett"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4254\/wjh.v6.i1.17","volume":"6","author":"Teschke R.","year":"2014","unstructured":"Teschke R, Wolff A, Frenzel C, Schwarzenboeck A, Schulze J, Eickhoff A. Drug and herb induced liver injury: Council for international organizations of medical sciences scale for causality assessment.","journal-title":"World J Hepatol"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","volume":"89","author":"Aithal G.P.","year":"2011","unstructured":"Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, Hunt CM, Wilke RA, Avigan M, Kaplowitz N, Bjornsson E, Daly AK. Case definition and phenotype standardization in drug-induced liver injury.","journal-title":"Clin Pharmacol Ther"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/pds.2127","volume":"20","author":"Teschke R.","year":"2011","unstructured":"Teschke R, Schmidt-Taenzer W, Wolff A. Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: is the liver-unspecific Naranjo scale precise enough to ascertain causality?","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3350\/cmh.2013.19.4.349","volume":"19","author":"Kim T.Y.","year":"2013","unstructured":"Kim TY, Kim D. Acute-on-chronic liver failure.","journal-title":"Clin Mol Hepatol"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/MOG.0b013e32833847c5","volume":"26","author":"Larson A.M.","year":"2010","unstructured":"Larson AM. Diagnosis and management of acute liver failure.","journal-title":"Curr Opin Gastroenterol"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/hep.20948","volume":"42","author":"Larson A.M.","year":"2005","unstructured":"Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, Reisch JS, Schi\u00f8dt FV, Ostapowicz G, Shakil AO, Lee WM. Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study.","journal-title":"Hepatology"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1155\/2011\/174978","volume":"25","author":"Krishna Y.R.","year":"2011","unstructured":"Krishna YR, Mittal V, Grewal P, Fiel MI, Schiano T. Acute liver failure caused by \u2018fat burners\u2019 and dietary supplements: A case report and literature and literature review.","journal-title":"Can J Gastroenterol"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1081\/DMR-120034148","volume":"36","author":"Gunawan B.","year":"2004","unstructured":"Gunawan B, Kaplowitz N. Clinical perspectives on xenobiotic induced hepatoxicity.","journal-title":"Drug Metab Rev"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/00007691-200112000-00018","volume":"23","author":"Stewart M.J.","year":"2001","unstructured":"Stewart MJ, Steenkamp V. Pyrrolizidine poisoning: A neglected area in human toxicology.","journal-title":"Ther Drug Monit"},{"key":"ref=85","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1365-2036.2003.01689.x","volume":"18","author":"Pittler M.H.","year":"2003","unstructured":"Pittler MH, Ernst E. Systematic review: Hepatotoxic events associated with herbal medicinal products.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref=86","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1089-3261(03)00030-8","volume":"7","author":"Schiano T.D.","year":"2003","unstructured":"Schiano TD. Hepatotoxicity and complementary and alternative medicines.","journal-title":"Clin Liver Dis"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-2002-30104","volume":"22","author":"Stedman C.","year":"2002","unstructured":"Stedman C. Herbal hepatotoxicity.","journal-title":"Semin Liver Dis"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1665-2681(19)31777-6","volume":"8","author":"Teschke R.","year":"2009","unstructured":"Teschke R, Bahre R. Severe hepatotoxicity by Indian Ayurvedic herbal products: A structured causality assessment.","journal-title":"Ann Hepatol"},{"key":"ref=89","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.dld.2010.12.012","volume":"43","author":"Dantuluri S.","year":"2011","unstructured":"Dantuluri S, North-Lewis P, Karthik SV. Gotu Kola induced hepatotoxicity in a child- need for caution with alternative remedies.","journal-title":"Dig Liver Dis"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4321\/S1130-01082005000200006","volume":"97","author":"Jorge O.A.","year":"2005","unstructured":"Jorge OA, Jorge AD. Hepatotoxicity associated with the ingestion of Centella asiatica.","journal-title":"Rev Esp Enferm Dig"},{"key":"ref=91","first-page":"127","volume":"126","author":"Fleig W.W.","year":"1997","unstructured":"Fleig WW, Morgan MY, Holzer MA. European multicenter study group. The ayurvedic drug Liv.52 in patients with alcoholic cirrhosis. Results of a prospective, randomized, double-blind, placebo-controlled clinical trial.","journal-title":"J Hepatol"},{"key":"ref=92","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/135965350701200316","volume":"12","author":"Modi A.A.","year":"2007","unstructured":"Modi AA, Wright EC, Leonard BS. Complementary and Alternative Medicine for the treatment of hepatitis B and C: A review.","journal-title":"Antivir Ther"},{"key":"ref=93","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1365-2036.2006.03111.x","volume":"24","author":"Yuen M.F.","year":"2006","unstructured":"Yuen MF, Tam S, Fung J, Wong DK, Wong BC, Lai CL. Traditional Chinese Medicine causing hepatotoxicity in patients with chronic hepatitis B infection: A 1-year prospective study.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref=94","doi-asserted-by":"crossref","first-page":"e16064","DOI":"10.1371\/journal.pone.0016064","volume":"6","author":"Lee C.H.","year":"2011","unstructured":"Lee CH, Wang JD, Chen PC. Risk of liver injury associated with Chinese herbal products containing Radix bupleuri in 639,779 patients with hepatitis B virus infection.","journal-title":"PLoS One"},{"key":"ref=95","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1001\/archsurg.138.8.852","volume":"138","author":"Estes J.D.","year":"2003","unstructured":"Estes JD, Stolpman D, Olyaei A, Corless CL, Ham JM, Schwartz JM, Orloff SL. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure.","journal-title":"Arch Surg"},{"key":"ref=96","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00006534-199508000-00041","volume":"96","author":"Petry J.J.","year":"1995","unstructured":"Petry JJ. Garlic and postoperative bleeding.","journal-title":"Plast Reconstr Surg"},{"key":"ref=97","first-page":"772","volume":"246","author":"Sunter W.H.","year":"1991","unstructured":"Sunter WH. Warfarin and garlic.","journal-title":"Pharm J"},{"key":"ref=98","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/01376517-200008000-00007","volume":"32","author":"Evans V.","year":"2000","unstructured":"Evans V. Herbs and the brain: Friend or foe? The effects of ginkgo and garlic on warfarin use.","journal-title":"J Neurosci Nurs"},{"key":"ref=99","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/jnnp.68.5.679a","volume":"68","author":"Galluzzi S.","year":"2000","unstructured":"Galluzzi S, Zanetti O, Binetti G, Trabucchi M, Frisoni GB. Coma in a patient with Alzheimer\u2019s disease taking low dose trazodone and Ginkgo biloba.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00004714-198706000-00030","volume":"7","author":"Jones B.D.","year":"1987","unstructured":"Jones BD, Runikis AM. Interaction of ginseng with phenelzine.","journal-title":"J Clin Psychopharmacol"},{"key":"ref=101","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1086\/324351","volume":"34","author":"Piscitelli S.C.","year":"2002","unstructured":"Piscitelli SC, Burstein AH, Welden N, Gallicano KD, Falloon J. The effect of garlic supplements on the pharmacokinetics of saquinavir.","journal-title":"Clin Infect Dis"},{"key":"ref=102","first-page":"223","volume":"70","author":"Sitprija S.","year":"1987","unstructured":"Sitprija S, Plengvidhya C, Kangkaya V, Bhuvapanich S, Tunkayoon M. Garlic and diabetes mellitus phase II clinical trial.","journal-title":"J Med Assoc Thai"},{"key":"ref=103","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/004982599238173","volume":"29","author":"Gorski J.C.","year":"1999","unstructured":"Gorski JC, Jones DR, Hamman MA, Wrighton SA, Hall SD. Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily.","journal-title":"Xenobiotica"},{"key":"ref=104","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1592\/phco.22.8.551.33205","volume":"22","author":"Piscitelli S.C.","year":"2002","unstructured":"Piscitelli SC, Formentini E, Burstein AH, Alfaro R, Jagannatha S, Falloon J. Effect of milk thistle on the pharmacokinetics of indinavir in healthy volunteers.","journal-title":"Pharmacotherapy"},{"key":"ref=105","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00045391-200307000-00003","volume":"10","author":"Mauro V.F.","year":"2003","unstructured":"Mauro VF, Mauro LS, Kleshinski JF. Khuder, S.A.; Wang, Y.; Erhardt, P.W. Impact of Ginkgo biloba on the pharmacokinetics of digoxin.","journal-title":"Am J Ther"},{"key":"ref=106","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2165\/00003495-200565090-00005","volume":"65","author":"Hu Z.","year":"2005","unstructured":"Hu Z, Yang X, Ho PC, Chan SY, Heng PW, Chan E, Duan W, Koh HL, Zhou S. Herb-drug interactions: A literature review.","journal-title":"Drugs"},{"key":"ref=107","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000334488","volume":"21","author":"Izzo A.A.","year":"2012","unstructured":"Izzo AA. Interactions between Herbs and conventional drugs: Overview of the clinical data.","journal-title":"Med Princ Pract"},{"key":"ref=","doi-asserted-by":"crossref","unstructured":"Tsukamoto, S; Aburatani, M; Ohta, T. Isolation of CYP3A4 inhibitors from the black cohosh (Cimicifuga racemosa). eCAM, 2005, 2, 223-226.","DOI":"10.1093\/ecam\/neh086"},{"key":"ref=109","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0944-7113(00)80044-6","volume":"7","author":"Budzinski J.W.","year":"2000","unstructured":"Budzinski JW, Foster BC, Vandenhoek S, Arnason JT. An evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures.","journal-title":"Phytomedicine"},{"key":"ref=110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.lfs.2009.04.023","volume":"85","author":"Toselli F.","year":"2009","unstructured":"Toselli F, Matthiasv A, Gillam EMJ. Echinacea metabolism and drug interactions: The case for standardization of a complementary medicine.","journal-title":"Life Sci"},{"key":"ref=111","doi-asserted-by":"crossref","first-page":"10578","DOI":"10.1021\/jf303534e","volume":"60","author":"Choi H.A.","year":"2012","unstructured":"Choi HA, Kim M-R, Park KA, Hong J. Interaction of over-the-Counter Drugs with Curcumin: Influence on Stability and Bioactivities in Intestinal Cells.","journal-title":"J Agric Food Chem"},{"key":"ref=112","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2174\/1389200211209050640","volume":"13","author":"Chen X-W.","year":"2012","unstructured":"Chen X-W, Sneed KB, Pan S-Y, Cao C, Kanwar JR, Chew H, Zhou S-F. Herb-drug interactions and mechanistic and clinical considerations.","journal-title":"Curr Drug Metab"},{"key":"ref=113","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2174\/1389200216666150223152348","volume":"15","author":"Meng Q.","year":"2014","unstructured":"Meng Q, Liu K. Pharmacokinetic interactions between herbal medicines and prescribed drugs: Focus on drug metabolic enzymes and transporters.","journal-title":"Curr Drug Metab"},{"key":"ref=114","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2174\/138920010794328913","volume":"11","author":"Darwich A.S.","year":"2010","unstructured":"Darwich AS, Neuhoff S, Jamei M, Rostami-Hodjegan A. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: A simulation assessment using the \u201cAdvanced Dissolution, Absorption, Metabolism (ADAM)\u201d model.","journal-title":"Curr Drug Metab"},{"key":"ref=115","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1089\/acm.2015.0235","volume":"22","author":"Choi J.G.","year":"2016","unstructured":"Choi JG, Eom SM, Kim J, Kim SH, Huh E, Kim H, Lee Y, Lee H, Oh MS. A Comprehensive review of recent studies on herb-drug interaction: A focus on pharmacodynamic interaction.","journal-title":"J Altern Complement Med NYN"},{"key":"ref=116","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.pbb.2011.05.011","volume":"99","author":"Reeta K.H.","year":"2011","unstructured":"Reeta KH, Mehla J, Pahuja M, Gupta YK. Pharmacokinetic and pharmacodynamic interactions of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats.","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=117","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1081\/DMR-120018248","volume":"35","author":"Zhou S.","year":"2003","unstructured":"Zhou S, Gao Y, Jiang W, Huang M, Xu A, Paxton JW. Interactions of herbs with cytochrome P450.","journal-title":"Drug Metab Rev"},{"key":"ref=118","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fphar.2012.00069","volume":"3","author":"Fasinu P.S.","year":"2012","unstructured":"Fasinu PS, Bouic PJ, Rosenkranz B. An overview of the evidence and mechanisms of herb-drug interactions.","journal-title":"Front Pharmacol"},{"key":"ref=119","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2125.2012.04350.x","volume":"75","author":"Posadzki P.","year":"2013","unstructured":"Posadzki P, Watson L, Ernst E. Herb-drug interactions: An overview of systematic reviews.","journal-title":"Br J Clin Pharmacol"},{"key":"ref=120","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1440-1797.2008.00940.x","volume":"13","author":"Nowack R.","year":"2008","unstructured":"Nowack R. Review article: Cytochrome P450 enzyme, and transport protein mediated herb-drug interactions in renal transplant patients: Grapefruit juice, St John\u2019s Wort - and beyond!","journal-title":"Nephrology"},{"key":"ref=121","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.taap.2012.05.020","volume":"263","author":"Yang S.Y.","year":"2012","unstructured":"Yang SY, Juang SH, Tsai SY, Chao PD, Hou YCSt. John\u2019s wort significantly increased the systemic exposure and toxicity of methotrexate in rats.","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=122","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1159\/000490525","volume":"12","author":"Lin K.","year":"2018","unstructured":"Lin K, Lin AN, Linn S, Hlaing PP, Vasudev V, Reddy M. Ginseng-related drug-induced liver injury.","journal-title":"Case Rep Gastroenterol"},{"key":"ref=123","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s40264-018-0654-2","volume":"41","author":"Danan G.","year":"2018","unstructured":"Danan G, Teschke R. Drug-induced liver injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) still used 25 years after its launch?","journal-title":"Drug Saf"},{"key":"ref=124","doi-asserted-by":"crossref","first-page":"E803","DOI":"10.3390\/ijms18040803","volume":"18","author":"Teschke R.","year":"2017","unstructured":"Teschke R, Schulze J, Eickhoff A, Danan G. Drug induced liver injury: Can biomarkers assist RUCAM in causality assessment?","journal-title":"Int J Mol Sci"}],"container-title":["Current Drug Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/170943","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T08:32:41Z","timestamp":1663144361000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/170943\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,11]]},"references-count":124,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,6,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389200220666190325141422","relation":{},"ISSN":["1389-2002"],"issn-type":[{"value":"1389-2002","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-10-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}